SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-18-000263
Filing Date
2018-02-20
Accepted
2018-02-20 16:08:54
Documents
1
Period of Report
2018-02-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT cymabaytherafm4_feb15018.html 4  
1 OWNERSHIP DOCUMENT cymabaytherafm4_feb15018.xml 4 6737
  Complete submission text file 0000905718-18-000263.txt   8311
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 GATEWAY BOULEVARD SUITE 350 SAN FRANCISCO CA 94080
Business Address
EMSTER KURT VON (Reporting) CIK: 0001252524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36500 | Film No.: 18624649